P3 Health Partners Inc. (PIII) P/E Ratio History
Historical price-to-earnings valuation from 2021 to 2021
Loading P/E history...
PIII Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, P3 Health Partners Inc. (PIII) trades at a price-to-earnings ratio of -0.1x, with a stock price of $3.58 and trailing twelve-month earnings per share of $-40.10.
The current P/E is 100% below its 5-year average of 84.0x. Over the past five years, PIII's P/E has ranged from a low of 84.0x to a high of 84.0x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, PIII trades at a 100% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, PIII trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our PIII DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
PIII P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $10B | 21.5Lowest | -Best | -56% | |
| $111B | 62.8 | -Best | -62% | |
| $30B | 25.1 | -Best | -1%Best | |
| $336B | 27.9 | -Best | -15% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
PIII Historical P/E Data (2021–2021)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2021 Q3 | $493.00 | $5.87 | 84.0x | +0% |
Average P/E for displayed period: 84.0x
See PIII's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PIII Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PIII vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPIII — Frequently Asked Questions
Quick answers to the most common questions about buying PIII stock.
Is PIII stock overvalued or undervalued?
PIII trades at -0.1x P/E, below its 5-year average of 84.0x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does PIII's valuation compare to peers?
P3 Health Partners Inc. P/E of -0.1x compares to sector median of 22.3x. The discount suggests lower growth expectations or higher risk.
What is PIII's PEG ratio?
PIII PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2021-2021.